Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
10,49 USD | +1,35% | -8,78% | -14,37% |
Omzet 2024 * | - | Omzet 2025 * | 16,49 mln. 15,38 mln. | Marktkapitalisatie | 443 mln. 413 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -114 mln. -106 mln. | Nettowinst (verlies) 2025 * | -110 mln. -103 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 218 mln. 204 mln. | Nettoliquiditeiten 2025 * | 105 mln. 97,62 mln. | EV/omzet 2025 * | 20,5 x |
K/w-verhouding 2024 * |
-3,45
x | K/w-verhouding 2025 * |
-4,39
x | Werknemers | 118 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,86% |
Recentste transcriptie over KalVista Pharmaceuticals, Inc.
1 dag | +1,35% | ||
1 week | -8,78% | ||
Lopende maand | -11,55% | ||
1 maand | -5,75% | ||
3 maanden | -18,37% | ||
6 maanden | +32,28% | ||
Lopend jaar | -14,37% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ed Feener
FOU | Founder | 64 | 26-03-04 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 01-08-16 |
Paul Audhya
CTO | Chief Tech/Sci/R&D Officer | 51 | 03-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Brian Pereira
CHM | Chairman | 65 | 01-02-19 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 01-08-16 |
Albert Cha
BRD | Director/Board Member | 51 | 01-01-16 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.04% | 2 M€ | -.--% | ||
0.03% | 0 M€ | 0,00% | - | |
0.00% | 9 M€ | +5,51% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 10,49 | +1,35% | 363 775 |
24-04-24 | 10,35 | -7,67% | 482 332 |
23-04-24 | 11,21 | -2,01% | 192 501 |
22-04-24 | 11,44 | -1,12% | 289 249 |
19-04-24 | 11,57 | +0,61% | 346 978 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,37% | 443 mln. | |
-4,74% | 87,53 mld. | |
+2,63% | 40,42 mld. | |
-21,76% | 29,48 mld. | |
+58,56% | 25,43 mld. | |
-14,78% | 15,59 mld. | |
-18,49% | 11,49 mld. | |
-15,61% | 11,1 mld. | |
-44,02% | 11,3 mld. | |
+5,17% | 8,75 mld. |